ADA's Scientific Sessions Coverage
ADA's Scientific Sessions Coverage
06/26/2025
Lois E. Donovan, MD; Denice Feig, MD, MSc, FRCPC
Lois E. Donovan, MD, and Denice Feig, MD, MSc, FRCPC, discuss their presentation at the 2025 American Diabetes Association Scientific Sessions, previewing results of a randomized multicenter study which...
06/26/2025
ADA's Scientific Sessions Coverage
ADA's Scientific Sessions Coverage
06/25/2025
Nestoras Mathioudakis, MD, MHS
Nestoras Mathioudakis, MD, MHS, shares findings from a randomized controlled trial comparing a fully automated, app-based diabetes prevention program with a standard CDC-recognized intervention,...
06/25/2025
ADA's Scientific Sessions Coverage
ADA's Scientific Sessions Coverage
06/24/2025
Tugce Akcan, MD
In this expert interview, Tugce Akcan, MD, discusses a novel approach to type 1 diabetes care using OpenAPS and GLP-1 receptor agonists to eliminate the need for prandial insulin boluses and improve patient...
06/24/2025
ADA's Scientific Sessions Coverage
ADA's Scientific Sessions Coverage
06/23/2025
Miranda Manier, BA
A study presented at the 85th Scientific Sessions of the American Diabetes Association explored how physical and cognitive limitations affect glucometer use in adults aged 65 years and older with type 2...
06/23/2025
ADA Conference Coverage
ADA Conference Coverage
06/22/2025
Anthony Calabro, MA
Continuous glucose monitoring adherence significantly lowers emergency and inpatient visits for diabetes-related complications in people with type 2 diabetes on intensive insulin therapy. The authors...
06/22/2025
ADA Conference Coverage
ADA Conference Coverage
06/22/2025
Kate Young
A new optical device using visible light photoplethysmography accurately measured blood glucose in patients with diabetes, achieving a MARD of 8.8% and 100% clinical agreement in the Consensus Error Grid....
06/22/2025
ADA Conference Coverage
ADA Conference Coverage
06/22/2025
Kate Young
A retrospective cohort study presented at the American Diabetes Association found that combining continuous glucose monitoring (CGM) with GLP-1 agonist therapy led to significantly greater reductions in...
06/22/2025
Research Summary
Research Summary
06/20/2025
Anthony Calabro, MA
A real-world study of a fasting mimicking diet program showed improved glycemic control, medication reduction, and weight loss in people with type 2 diabetes, with high engagement and satisfaction rates....
06/20/2025
AACE Conference Coverage
AACE Conference Coverage
05/17/2025
Anthony Calabro, MA
A post hoc analysis of the SURMOUNT-1 trial reveals that cardiometabolic improvements achieved after 176 weeks of tirzepatide may diminish significantly within 17 weeks of treatment cessation, particularly...
05/17/2025
Roundtable Wrap-Up
Roundtable Wrap-Up
07/19/2024
In this Roundtable Wrap-Up, we offer an abbreviated version of the roundtable discussion on the multidisciplinary approach to managing patients with diabetes and the value of utilizing the services of a...
07/19/2024